Resources

Find the publications relevant to your drug development programs.

    Drug Type

    Cancer Type

    Need Help?

    Contact Us for support

    May 10, 2021

    Inhibition of IDO activity by epacadostat (INCB024360) activates tumor infiltrating lymphocytes in a patient-derived 3D ex vivo system of lung cancer and alleviates stromal immunosuppression
    resource1

    May 10, 2021

    Impact of combined blockade of PD1 and activation of CD137 on tumor infiltration and tumor cell killing efficacy of TILs in an ex vivo autologous 3D tumoroid model of NSCLC patient samples
    resource1

    Oct 21, 2020

    An ex vivo tumoroid model of fresh patient tumors (3D-ACTSM) to assess efficacy of cellular therapy in immuno-oncology
    resource1

    Oct 21, 2020

    Determining the efficacy of ADCC by the 3D-EXSM ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment
    resource1

    Oct 21, 2020

    Evaluating the effectiveness of targeting ADC therapy in a patient-derived ex vivo tumoroid model, 3D-EX, for quantitative tumor cell killing
    resource1